Regenerative Medicine Trials in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Regenerative Medicine Trials in Argentina

Regenerative Medicine Trials in Argentina – Human Trials in LATAM

Regenerative medicine, a groundbreaking field that harnesses the body’s own healing mechanisms to treat and potentially cure diseases, has gained momentum worldwide. Argentina, a country known for its rich scientific heritage, has embarked on a remarkable journey in the realm of regenerative medicine trials.

In this blog, we delve into the thriving landscape of regenerative medicine trials in Argentina, shedding light on the latest advancements, challenges, and the transformative potential for healthcare.

Argentina’s Leap into Regenerative Medicine

Regenerative medicine encompasses a spectrum of approaches, including stem cell therapy, tissue engineering, and gene editing. Argentina’s vibrant scientific community has embraced these avenues, leading to groundbreaking trials that hold promise for innovative medical solutions.

Stem Cell Therapy Endeavors

Stem cell therapy, a cornerstone of regenerative medicine, has gained significant traction in Argentina. Clinical trials are underway to explore the potential of mesenchymal stem cells (MSCs) derived from sources such as bone marrow and umbilical cord tissue. These trials aim to address a wide range of conditions, from orthopedic injuries to degenerative diseases, showcasing Argentina’s dedication to providing cutting-edge treatments that can transform patient outcomes.

Tissue Engineering Innovations

Tissue engineering, a field focused on creating functional tissues or organs, has also found a fertile ground in Argentina. Researchers are actively engaged in trials to develop tissue-engineered solutions for wound healing, cartilage repair, and organ transplantation. These efforts underline Argentina’s commitment to advancing medical science and offering novel therapies to meet critical healthcare needs.

Gene Editing Breakthroughs

The transformative potential of gene editing technologies has not gone unnoticed by Argentina’s research community. Gene therapy trials are exploring innovative ways to modify genetic material to treat inherited disorders and genetic diseases.

By addressing the underlying genetic causes, these trials offer a glimmer of hope for treatments that were once considered unattainable. Argentina’s participation in gene editing research reflects its determination to push the boundaries of scientific exploration.

Regenerative Medicine Trials in Argentina

Regenerative Medicine Trials in Argentina

Regenerative Medicine Trials in Argentina

Navigating Challenges and Ethical Considerations

While regenerative medicine trials open doors to unprecedented medical advancements, they also come with ethical considerations and challenges. Ensuring patient safety, ethical practices, and adherence to regulatory guidelines are paramount. Argentina’s regulatory bodies and research institutions are actively working to strike a balance between scientific progress and ethical responsibility, ensuring that these trials contribute to the betterment of healthcare.

Global Collaboration and Knowledge Exchange

Argentina’s pursuit of excellence in regenerative medicine extends beyond its borders through collaborations and partnerships with international research institutions.

By fostering connections and sharing insights with experts worldwide, Argentina aims to accelerate its progress and contribute to the global regenerative medicine community. These collaborations facilitate the exchange of ideas, expertise, and resources, fostering an environment of shared learning and mutual growth.

Potential Transformative Impact on Healthcare

The potential impact of regenerative medicine trials in Argentina extends beyond scientific advancement. Successful outcomes could lead to the development of groundbreaking treatments for a diverse array of conditions, elevating patient care and reducing the burden on healthcare systems.

Furthermore, Argentina’s emergence as a regenerative medicine hub has the potential to attract medical tourism, driving economic growth and positioning the country as a beacon of medical innovation.


Argentina’s foray into the realm of regenerative medicine trials is a testament to its dedication to scientific progress and healthcare innovation. Stem cell therapy, tissue engineering, and gene editing trials reflect the country’s pioneering spirit and commitment to pushing the boundaries of medical science.

As Argentina navigates ethical considerations and collaborates with global partners, it is poised to play a pivotal role in shaping the future of regenerative medicine.

These ongoing trials serve as a beacon of hope, not only for Argentine patients but for the broader global community seeking transformative medical solutions. Argentina’s journey is a testament to the power of scientific exploration and its potential to revolutionize healthcare as we know it.

Regenerative Medicine Trials in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Regenerative Medicine Trials in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Regenerative Medicine Trials in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Regenerative Medicine Trials in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Regenerative Medicine Trials in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Regenerative Medicine Trials in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Regenerative Medicine Trials in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Regenerative Medicine Trials in Argentina

The Cohortias Team

Regenerative Medicine Trials in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Regenerative Medicine Trials in Argentina

Network & Partnerships